Does RAVULIZUMAB-CWVZ Cause C-reactive protein increased? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of C-reactive protein increased have been filed in association with RAVULIZUMAB-CWVZ. This represents 0.1% of all adverse event reports for RAVULIZUMAB-CWVZ.
7
Reports of C-reactive protein increased with RAVULIZUMAB-CWVZ
0.1%
of all RAVULIZUMAB-CWVZ reports
1
Deaths
4
Hospitalizations
How Dangerous Is C-reactive protein increased From RAVULIZUMAB-CWVZ?
Of the 7 reports, 1 (14.3%) resulted in death, 4 (57.1%) required hospitalization.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower C-reactive protein increased Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST